Conference room
09:0009:05
Workshop opening (Piotr Rutkowski, Warsaw/Poland)
5 min
09:0509:30
Workshop session 1
(Lead: Kadri Putnik, Talin/Estonia)
25 min

09:05 - 09:15

Case report of a patient receiving tebentafusp (2+ line) over 52 weeks

09:15 - 09:30

Q&A session
09:3009:55
Workshop session 2
(Lead: Luka Simetić, Zagreb/Croatia)
25 min

09:30 - 09:40

Heterogeneous UM cells with BRAF mutations — long time survival on tebentafusp

09:40 - 09:55

Q&A session
09:5510:05
Break 10 min
10:0510:30
Workshop session 3
(Lead: Vincas Urbonas, Vilnius/Lithuania)
25 min

10:05 - 10:15

Case report of a patient with 4th line tebentafusp treatment

10:15 - 10:30

Q&A session
10:3010:55
Workshop session 4
(Lead: Paweł Rogala, Warsaw/Poland)
25 min

10:30 - 10:40

Case report of a pregnant patient diagnosed with mUM

10:40 - 10:55

Q&A session
 
10:5511:00
Summary and closing remarks
(Piotr Rutkowski, Warsaw/Poland)
5 min
Copyrights © 2024 Via Medica